Genetic Technologies was an early pioneer in recognizing important new applications for "non-coding" DNA (DeoxyriboNucleic Acid). The Company has since been granted patents in 24 countries around the world, securing intellectual property rights for particular uses of non-coding DNA in genetic analysis and gene mapping across all genes in all multicellular species. Its three-pronged business strategy includes: 1) the global commercialization of its patents through an active licensing program; 2) the expansion of its dominant commercial genetic testing business in Australia; and, 3) the commercialization of its various research and development projects aimed at generating further intellectual property of global commercial significance.
Genetic Technologies Limited
ASX:GTG ISIN:AU000000GTG7
ニュース
銀行に引っ張られ午後に株式が早期上昇をあきらめたため、水曜日のオーストラリア株式市場は活気なく終了した。投資家が鉄鉱石価格に楽観的であったため鉱業は上昇した。取引終了時のS&P/オーストラリア証券取引所200銘柄の基準指数は1.6ポイント上昇し4925.9ポイント、全株価指数は7.7ポイント・0.15%上昇し4947.2ポイントとなった。
###
48,594 会社概要の閲覧回数
- 日本語ページ閲覧回数: (過去7日間: 13) (過去30日間: 48) (発行以降: 8414)